Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer

NCT01824901 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

2

Enrollment

NETWORK

Sponsor class

Conditions

Recurrent Non-small Cell Lung Cancer
Squamous Cell Lung Cancer

Interventions

DRUG: docetaxel
DRUG: AZD4547

Sponsor

ECOG-ACRIN Cancer Research Group

Collaborators

[object Object]